Prehospital invasive vs. non-invasive blood pressure monitoring: Impact on shock index at hospital admission in critically ill patients - a prospective intervention study

院前有创与无创血压监测:对危重患者入院时休克指数的影响——一项前瞻性干预研究

阅读:1

Abstract

OBJECTIVES: Hypotension and shock are potential modifiable contributors to adverse outcome. Inhospital, invasive blood pressure (IBP) monitoring is standard, while prehospital care mainly uses non-invasive blood pressure measurement. This study tested whether prehospital IBP monitoring improves shock index (SI) at hospital admission. METHODS: This prospective interventional study included patients requiring prehospital intubation, catecholamines, or fluid resuscitation. Patients were assigned to prehospital IBP or Non-IBP group - according to the directives of the emergency physician. Primary endpoint was the SI at hospital admission. Secondary endpoints included catecholamines doses, fluid volume and arterial blood gas parameters (pH, lactate, base excess) at admission. Multiple regression analysis assessed whether IBP independently influenced SI at hospital admission. RESULTS: 392 patients were enrolled, and 19.6% (n = 77) had prehospital IBP. The IBP group had a significantly lower shock index at hospital admission (mean ± SD: 0.77 ± 0.4 with IBP vs. 0.93 ± 0.5 with NIBP; p = 0.002). Multiple regression analysis showed that IBP was independently associated with a lower shock index. IBP patients received more catecholamine boluses (2.1 ± 2.5 vs. 1.2 ± 1.8; p < 0.001), had more frequent use of continuous catecholamines (35.1% vs. 21.6%; p = 0.017), higher pH (7.34 ± 0.13 vs. 7.25 ± 0.16; p < 0.001) and less negative base excess (-3,8 ± 5.2 vs. -6.0 ± 7.8; p = 0.004) while lactate levels were lower (3.6 ± 3.2 vs. 4.4 ± 4.2; p = 0.047). CONCLUSIONS: Prehospital IBP monitoring significantly was associated with a decreased shock index at hospital admission in critically ill patients, likely due to earlier detection of hypotension and targeted hemodynamic therapy. IBP should be considered in patients receiving catecholamines.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。